Financhill
Buy
59

DXCM Quote, Financials, Valuation and Earnings

Last price:
$67.28
Seasonality move :
9.19%
Day range:
$66.75 - $67.51
52-week range:
$54.11 - $93.25
Dividend yield:
0%
P/E ratio:
37.52x
P/S ratio:
6.08x
P/B ratio:
9.65x
Volume:
948.1K
Avg. volume:
5.3M
1-year change:
-15.98%
Market cap:
$26.3B
Revenue:
$4B
EPS (TTM):
$1.80

DexCom, Inc. SEC Filings

Company Filed Form Type Description
DXCM
DexCom, Inc.
04/25/2024 10-Q 10-Q filing on 04/25/2024 View Form
DXCM
DexCom, Inc.
10/26/2023 10-Q 10-Q filing on 10/26/2023 View Form
DXCM
DexCom, Inc.
07/27/2023 10-Q 10-Q filing on 07/27/2023 View Form
DXCM
DexCom, Inc.
04/27/2023 10-Q 10-Q filing on 04/27/2023 View Form
DXCM
DexCom, Inc.
10/27/2022 10-Q 10-Q filing on 10/27/2022 View Form
DXCM
DexCom, Inc.
07/28/2022 10-Q 10-Q filing on 07/28/2022 View Form
DXCM
DexCom, Inc.
04/28/2022 10-Q 10-Q filing on 04/28/2022 View Form
DXCM
DexCom, Inc.
10/28/2021 10-Q 10-Q filing on 10/28/2021 View Form
DXCM
DexCom, Inc.
07/29/2021 10-Q 10-Q filing on 07/29/2021 View Form
DXCM
DexCom, Inc.
04/29/2021 10-Q 10-Q filing on 04/29/2021 View Form
DXCM
DexCom, Inc.
02/11/2021 10-K 10-K filing on 02/11/2021 View Form
DXCM
DexCom, Inc.
10/27/2020 10-Q 10-Q filing on 10/27/2020 View Form
DXCM
DexCom, Inc.
07/28/2020 10-Q 10-Q filing on 07/28/2020 View Form
DXCM
DexCom, Inc.
04/28/2020 10-Q 10-Q filing on 04/28/2020 View Form
DXCM
DexCom, Inc.
02/13/2020 10-K 10-K filing on 02/13/2020 View Form
DXCM
DexCom, Inc.
11/06/2019 10-Q 10-Q filing on 11/06/2019 View Form
DXCM
DexCom, Inc.
07/31/2019 10-Q 10-Q filing on 07/31/2019 View Form
DXCM
DexCom, Inc.
05/01/2019 10-Q 10-Q filing on 05/01/2019 View Form
DXCM
DexCom, Inc.
02/21/2019 10-K 10-K filing on 02/21/2019 View Form
DXCM
DexCom, Inc.
11/06/2018 10-Q 10-Q filing on 11/06/2018 View Form
DXCM
DexCom, Inc.
08/01/2018 10-Q 10-Q filing on 08/01/2018 View Form
DXCM
DexCom, Inc.
05/02/2018 10-Q 10-Q filing on 05/02/2018 View Form
DXCM
DexCom, Inc.
02/27/2018 10-K 10-K filing on 02/27/2018 View Form
DXCM
DexCom, Inc.
11/01/2017 10-Q 10-Q filing on 11/01/2017 View Form
DXCM
DexCom, Inc.
08/01/2017 10-Q 10-Q filing on 08/01/2017 View Form
DXCM
DexCom, Inc.
05/02/2017 10-Q 10-Q filing on 05/02/2017 View Form
DXCM
DexCom, Inc.
02/28/2017 10-K 10-K filing on 02/28/2017 View Form
DXCM
DexCom, Inc.
11/01/2016 10-Q 10-Q filing on 11/01/2016 View Form
DXCM
DexCom, Inc.
08/02/2016 10-Q 10-Q filing on 08/02/2016 View Form
DXCM
DexCom, Inc.
04/27/2016 10-Q 10-Q filing on 04/27/2016 View Form
DXCM
DexCom, Inc.
02/23/2016 10-K 10-K filing on 02/23/2016 View Form

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is DocuSign Stock Undervalued?
Is DocuSign Stock Undervalued?

Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…

Is SentinelOne Stock Undervalued?
Is SentinelOne Stock Undervalued?

Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…

Is Broadcom Stock on Sale?
Is Broadcom Stock on Sale?

Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…

Stock Ideas

Buy
57
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Buy
55
Is AAPL Stock a Buy?

Market Cap: $4T
P/E Ratio: 37x

Buy
61
Is GOOG Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 39x

Alerts

Buy
80
TVTX alert for Dec 26

Travere Therapeutics, Inc. [TVTX] is down 0.7% over the past day.

Buy
64
ZCSH alert for Dec 26

Grayscale Zcash Trust (ZEC) [ZCSH] is down 0.71% over the past day.

Buy
66
ASTS alert for Dec 26

AST Spacemobile, Inc. [ASTS] is down 7.39% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock